bpc 157 name BPC-157 What is BPC-157? | Everything

Gill K, Jakubik J, Kups M, et al

Clinical trial safety data: In the Phase 2 trial, adverse events were comparable to placebo

These include: Neurological symptoms : tingling or numbness in hands and feet (peripheral neuropathy), difficulty walking or balance problems, memory difficulties, or mood changes including depression Haematological signs : persistent fatigue, weakness, pale or jaundiced skin, or shortness of breath Glossitis : a sore, red, smooth tongue Cognitive symptoms : difficulty concentrating, confusion, or "brain fog" Seek urgent medical attention if you experience rapidly worsening neurological symptoms, significant difficulty walking, severe paraesthesia, or marked cognitive decline, as these may require immediate assessment

We have a true love for combining the health and beauty industry to help our clients feel confident in themselves

But is BPC-157 really all its hyped up to be